TARPEYO - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of a United States Navy unmanned surface vessel operating near a naval warship, illustrating the US Navy’s MASC programme cancellation and the launch of the $2.1 billion MUSV marketplace under the Golden Fleet strategy.

US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement

No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies

Representative image of the BA.3.2 “Cicada” COVID variant under surveillance as the Centers for Disease Control and Prevention tracks detections across 25 United States states and the World Health Organization flags potential immune escape risk.

CDC tracks BA.3.2 Cicada COVID variant across 25 US states as WHO flags immune escape risk

A small imaging trial could reshape how brain metastases are detected and Radiopharm Theranostics is betting on it (ASX: RAD)

Calliditas Therapeutics secures TARPEYO FDA approval for IgAN treatment

Read More

2 minute read

Pharma Industry News

Calliditas Therapeutics bags TARPEYO FDA approval for IgAN

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) has announced a landmark FDA approval for TARPEYO (budesonide) delayed…

byPallavi Madhiraju

December 21, 2023

web analytics